Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/12/24 16:17 | 11/7/24 | CCCC | Health | BioPrd | Biological Products, (No Diag | Boyle Scott N | MA | O | Chief Bu | 2 | M.d | 0 | 0.00 | 0 | 6 | 12 | 57 | D | ||||||||||||||
11/12/24 16:17 | 11/7/24 | CCCC | Health | BioPrd | Biological Products, (No Diag | Adams Kendra | MA | O | CFO | 2 | M.d | 0 | 0.00 | 0 | 6 | 8 | 84 | D | ||||||||||||||
11/12/24 16:17 | 11/7/24 | CCCC | Health | BioPrd | Biological Products, (No Diag | Schick Kelly | MA | O | Chief Pe | 2 | M.d | 0 | 0.00 | 0 | 6 | 12 | 56 | D | ||||||||||||||
11/12/24 16:17 | 11/7/24 | CCCC | Health | BioPrd | Biological Products, (No Diag | Siegel Jolie | MA | O | GC | 2 | M.d | 0 | 0.00 | 0 | 6 | 12 | 56 | D | ||||||||||||||
11/12/24 16:17 | 11/7/24 | CCCC | Health | BioPrd | Biological Products, (No Diag | Hirsch Andrew | MA | DO | P,CEO | 2 | M.d | 0 | 0.00 | 0 | 20 | 10 | 222 | D | ||||||||||||||
9/17/24 17:12 | 9/16/24 | CCCC | Health | BioPrd | Biological Products, (No Diag | Fisher Stewart | MA | O | Chief Sc | 1 | M.d | 0 | 0.00 | 0 | 2 | 2 | 131 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |